Connect with us

Cannabis

Legend Cannabis Chocolate Available for Purchase

Published

on

New cannabis brand delivers high-quality cannabis-infused chocolate to Canadian consumers

Cranbrook, British Columbia–(Newsfile Corp. – June 10, 2020) – Dycar Pharmaceuticals Ltd. (Dycar” or “the Company“) is pleased to announce that its first product, Legend milk and dark chocolate, is now available for purchase in Alberta and British Columbia. Scored into four breakable pieces, Legend combines 10 mg of THC with 10 g of rich, premium chocolate. The chocolate used by Legend comes from Master Chocolat, led by fourth-generation master chocolatier, Bernard Callebaut. Legend’s chocolate uses organic, fair-trade and sustainably-sourced ingredients.

“We created the Legend brand to bring west coast cannabis and chocolate expertise to Canadians,” Scott Badcock, Dycar’s President, said. “With our cannabis grown in the Kootenay region of British Columbia and chocolate formulated by Master Chocolat, led by Bernard Callebaut, we see Legend as a marriage between some of the most talented experts that Western Canada has to offer. We are excited to bring our first product to market and look forward to all that is next for Legend.”

Legend’s milk and dark chocolate is expected to be released in Saskatchewan, Manitoba and Ontario within the next month.

ABOUT LEGEND

Legend Cannabis is sourced from leading genetics and hydroponically grown in the iconic Kootenay region of British Columbia. We produce chocolates, hand-crafted pre-rolls, rich flower and other premium products. Learn more about Legend at www.legendcannabis.com or on Instagram.

MEDIA AND INVESTOR CONTACT
Scott Badcock, President
Phone: 778-897-1970
Email: [email protected]

DISCLAIMER AND READER ADVISORY

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future product offerings, the expected timing of product releases, and compliance with applicable regulations.. Actual results and developments may differ materially from those that are currently contemplated by these statements depending on, among other things, risks relating to future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; general business, economic, competitive, political, regulatory and social uncertainties; the delay or failure to receive regulatory approvals; the COVID-19 pandemic nationally and globally which could have a material adverse impact on the Company’s business, operations and financial results, including disruptions in supply chains, as well as a deterioration of general economic conditions including national and/or global recessions; and the recreational cannabis industry in Canada generally. The Company cautions that the foregoing list of risks and uncertainties is not exhaustive. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57586

Cannabis

Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care

Published

on

Continue Reading

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania